Postoperative complications of minimally invasive esophagectomy for esophageal cancer
- PMID: 32258977
- PMCID: PMC7105848
- DOI: 10.1002/ags3.12315
Postoperative complications of minimally invasive esophagectomy for esophageal cancer
Abstract
Minimally invasive esophagectomy (MIE) has been performed increasingly more frequently for the treatment of esophageal cancer, ever since it was first described in 1992. However, the incidence of postoperative complications of MIE has not yet been well-characterized, because (a) there are few reports of studies with a sufficient sample size, (b) a variety of minimally invasive surgical techniques are used, and (c) there are few reports in which an established system for classifying the severity of complications is examined. According to an analysis performed by the Esophageal Complications Consensus Group, the most common complications of MIE are pneumonia, arrhythmia, anastomotic leakage, conduit necrosis, chylothorax, and recurrent laryngeal nerve palsy. Therefore, we decided to focus on these complications. We selected 48 out of 1245 reports of studies (a) that included more than 50 patients each, (b) in which the esophagectomy technique used was clearly described, and (c) in which the complications were adequately described. The overall incidences of the postoperative complications of MIE for esophageal cancer were analyzed according to the MIE technique adopted, that is, McKeown MIE, Ivor Lewis MIE, robotic-assisted McKeown MIE, robotic-assisted Ivor Lewis MIE, or mediastinoscopic transmediastinal esophagectomy. Pneumonia, arrhythmia, anastomotic leakage, and recurrent laryngeal nerve palsy occurred at an incidence rate of about 10% each; Ivor Lewis MIE was associated with a relatively low incidence of recurrent laryngeal nerve palsy. It is important to recognize that the incidences of complications of MIE are influenced by the MIE technique adopted and the extent of lymph node dissection.
Keywords: Ivor Lewis esophagectomy; McKeown esophagectomy; complication; minimally invasive esophagectomy; transmediastinal esophagectomy.
© 2020 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterological Surgery.
Conflict of interest statement
Conflict of Interest: The authors have no conflicts of interests to declare.
Similar articles
-
[Clinical observation on perioperative complications of minimally invasive Ivor-Lewis and minimally invasive McKeown esophagectomy].Zhonghua Zhong Liu Za Zhi. 2022 Jun 23;44(6):577-580. doi: 10.3760/cma.j.cn112152-20200704-00626. Zhonghua Zhong Liu Za Zhi. 2022. PMID: 35754233 Chinese.
-
McKeown or Ivor Lewis totally minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal junction: systematic review and meta-analysis.J Thorac Dis. 2017 Jul;9(Suppl 8):S826-S833. doi: 10.21037/jtd.2017.03.173. J Thorac Dis. 2017. PMID: 28815080 Free PMC article.
-
A comparison of short-term outcomes between Ivor-Lewis and McKeown minimally invasive esophagectomy.J Thorac Dis. 2015 Dec;7(12):2352-8. doi: 10.3978/j.issn.2072-1439.2015.12.15. J Thorac Dis. 2015. PMID: 26793358 Free PMC article.
-
Robot-assisted minimally invasive esophagectomy for esophageal cancer: Meticulous surgery minimizing postoperative complications.Ann Gastroenterol Surg. 2020 Aug 16;4(6):608-617. doi: 10.1002/ags3.12390. eCollection 2020 Nov. Ann Gastroenterol Surg. 2020. PMID: 33319150 Free PMC article. Review.
-
Comparison of short-term outcomes between minimally invasive McKeown and Ivor Lewis esophagectomy for esophageal or junctional cancer: a systematic review and meta-analysis.Onco Targets Ther. 2018 Sep 20;11:6057-6069. doi: 10.2147/OTT.S169488. eCollection 2018. Onco Targets Ther. 2018. PMID: 30275710 Free PMC article. Review.
Cited by
-
International consensus statement on robot-assisted minimally invasive esophagectomy (RAMIE).J Thorac Dis. 2020 Dec;12(12):7387-7401. doi: 10.21037/jtd-20-1945. J Thorac Dis. 2020. PMID: 33447428 Free PMC article. Review. No abstract available.
-
Minimally Invasive Surgery for Esophageal Cancer in Japan.Ann Thorac Cardiovasc Surg. 2020 Aug 20;26(4):179-183. doi: 10.5761/atcs.ed.20-00079. Epub 2020 Aug 1. Ann Thorac Cardiovasc Surg. 2020. PMID: 32741882 Free PMC article. No abstract available.
-
Application of Amiodarone and Cedilan in the Treatment of Patients with Arrhythmia after Esophageal and Lung Cancer.Evid Based Complement Alternat Med. 2023 Apr 13;2023:8026918. doi: 10.1155/2023/8026918. eCollection 2023. Evid Based Complement Alternat Med. 2023. Retraction in: Evid Based Complement Alternat Med. 2023 Dec 6;2023:9876708. doi: 10.1155/2023/9876708. PMID: 37089714 Free PMC article. Retracted.
-
Essential updates 2022/2023: Recent advances in perioperative management of esophagectomy to improve operative outcomes.Ann Gastroenterol Surg. 2024 Jul 29;8(6):966-976. doi: 10.1002/ags3.12847. eCollection 2024 Nov. Ann Gastroenterol Surg. 2024. PMID: 39502734 Free PMC article. Review.
-
C-reactive protein to prealbumin ratio: a useful inflammatory and nutritional index for predicting prognosis after curative resection in esophageal squamous cell carcinoma patients.Langenbecks Arch Surg. 2022 Aug;407(5):1901-1909. doi: 10.1007/s00423-022-02508-6. Epub 2022 Apr 14. Langenbecks Arch Surg. 2022. PMID: 35420308
References
-
- Cuschieri A, Shimi S, Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb. 1992;37(1):7–11. - PubMed
-
- McKeown KC. Total three‐stage oesophagectomy for cancer of the oesophagus. Br J Surg. 1976;63(4):259–62. - PubMed
-
- Lewis I. The surgical treatment of carcinoma of the oesophagus; with special reference to a new operation for growths of the middle third. Br J Surg. 1946;34:18–31. - PubMed
Publication types
LinkOut - more resources
Full Text Sources